Biomedical Catalyst

Our vision is to build a network of innovative, commercially viable life science businesses that transform healthcare and patients’ lives and drive business growth.

Transforming innovative ideas into commercially viable businesses

Innovate UK will drive transformational change in food production, wellness, early detection and treatment of disease to underpin population health and economic growth in the UK.

Through our flagship grant funding mechanism, Innovate UK Biomedical Catalyst, we help small and medium sized businesses test and develop innovative health and care solutions across life sciences, including therapeutics, medical devices, and digital health.

Biomedical Catalyst 2023 Round 2: Industry-led R&D is now open for applications (closing 8th November 2023).

Supporting Economic Success in Health and Life Sciences

The Biomedical Catalyst is Innovate UK’s flagship grant funding mechanism, enabling small and medium sized businesses to test and develop innovative health and care solutions across life sciences, including therapeutics, medical devices and digital health.

How we support

We recognise that grant funding alone is not enough, and projects need to be supported as an ecosystem to be able to easily access the partners needed on their innovation journey such as regulators, accelerators, supply chain, systems-based design, global markets and investors. Learn how the Innovate UK system can each uniquely help you achieve your innovation goals.

  • Innovate UK Business Connect: Connecting innovators with new partners and new opportunities beyond their existing thinking – accelerating ambitious ideas into real-world solutions. If you want help to find a project partner or would like someone to review your application before submission, contact Innovate UK Business Connect.
  • Innovate UK Business Growth: Bespoke advice and support to help grow & scale innovative businesses. If you’re looking for intensive support with your growth strategy, including exploiting innovation, securing funding & finance and entering new markets, please contact Innovate UK Business Growth.

The Biomedical Catalyst supports small and medium sized businesses, of all stages, to:

  • Get your project to market quicker
  • De-risk your early stage innovations and projects, and lower risk for investors
  • Bring in private capital alongside grants for projects

Biomedical Catalyst is technology agnostic, we want to fund a variety of projects across different markets, technologies, strands and themes.

How it works

By awarding grants to UK-based businesses of varying stages of development, we enable them to develop innovative healthcare solutions, secure investment and speed up bringing new products to market.
  • Biomedical Catalyst is technology agnostic, we want to fund a variety of projects across different markets, technologies, strands and themes including:

    Medicines & Pharmaceuticals

    • Innovative drug discovery and delivery
    • Therapeutic and medicine development
    • Advanced therapies

    Health Technology

    • Diagnostics
    • Imaging
    • Medical technology and devices
    • Sensors
    • Robotics

    Digital Health Technology

    • Data driven health
    • AI in health
    • Independent living and wellbeing
  • Opportunity to gain financial support for market and technology feasibility studies

    Innovate UK, in partnership with Medical Research Council, will support the development of early-stage health and life science businesses in the UK by funding a series of business accelerators in thematic areas. These accelerators will recruit spinouts, start-ups, and entrepreneurial minded academics to test their ideas and develop concepts with support from key stakeholders from relevant ecosystems.

    We want accelerators to support organisations with the potential to enable fair, impartial and sustainable forms of community participation in research across the UK.

    Over a set period of time, through online and in-person workshops, you will:

    • Receive advise and support including scientific, commercial, regulatory and investment expertise
    • Receive a package of training that instils the fundamentals of commercialisation and entrepreneurship

    At the end of the accelerator you will/should be in a position to seek investment, or feasibility grant funding of £100k-£150k at 100% via a closed competition.

  • Transformational grant funding for industry-led innovation projects

    Designed to provide support for pre-market R&D projects aimed at developing innovative solutions to address challenges in health and healthcare.

    Projects should demonstrate both commercial and technical feasibility through existing evidence, and show how the project will enhance the competitiveness and productivity of at least one participating UK SME.  We will fund industrial research projects and experimental development projects, as defined in the guidance on categories of research.

    Key features:

    • Project costs £150k-£4m 
    • Grant up for £2m 
    • 70% grant support for SMEs 
    • Project duration 6-36 months
  • De-risking innovative technologies by aligning public grant and private enterprise investment

    The Innovate UK Investor Partnerships Programme is a three-year initiative to boost Future Economy-focused SMEs through aligning grant funding for R&D development with investment from partnerships with credible investor partners.

Our Experts

Related Opportunities

NHS Cancer Programme: Innovation Open Call 3

Opens: 26/01/2024 Closes: 29/05/2024

NHS England has launched a new round of its funding competition for innovation in the early detection and diagnosis of cancer.

More Information

Open Innovation Challenge: Next-generation digital learning tools for community health workers

Opens: 12/02/2024 Closes: 22/03/2024

AMREF Health Africa is looking to transform its digital learning tools for community health workers, using next-generation technologies.

More Information

Mobile Evidential Drug Testing Instrument (MEDTI) Demonstrator

Opens: 19/02/2024 Closes: 16/04/2024

The DfT are seeking innovations to develop roadside evidential drug testing capability to enable effective enforcement of drug driving offending.

More Information

Related Case Studies

A remote monitoring service for cancer patients that restores quality of life

A remote monitoring service for cancer patients that restores quality of life

Cancer patients can now monitor symptoms and take their own blood tests in the comfort of their own home. Entia delivers a remote monitoring service designed to reduce the need for hospital visits, spot treatment side effects earlier, and ultimately improve a person’s quality of life and outcomes.

Learning from nature to identify new antibody-like proteins to treat complex autoimmune diseases

Learning from nature to identify new antibody-like proteins to treat complex autoimmune diseases

“Antibodies are phenomenal molecules keeping us healthy. But clinically they can be limited,” explains Dr Caroline Barelle, CEO and co-founder of Elasmogen. “Relatively speaking, human antibodies are large and complex. They are good anywhere there is blood but are less effective where there is a barrier, like a solid tumour. If they were smaller, you could get deeper into the tissue and be more effective.”

Screening technology that seeks out new targets to drug the “undruggable”

Screening technology that seeks out new targets to drug the “undruggable”

Small molecule drugs are effective because they bind to the surface of a disease-relevant protein in the human body. But currently, around 85% of human proteins remain “undruggable” because scientists haven’t yet found the site, or pocket, on the surface that a drug can bind to.

Related News

Help us shape the future of innovation!

11/07/2023

Help us shape the future of innovation!

Innovate UK is looking to expand their assessor pool to review applications in the Health and Life Sciences area. Join us and be part of a vibrant community of experts dedicated to driving innovation forward.

Read more
Pilot accelerators launched to support the development of early-stage health and life science innovation in the UK

02/05/2023

Pilot accelerators launched to support the development of early-stage health and life science innovation in the UK

We are pleased to announce our pilot accelerators, in collaboration with the Medical Research Council (MRC), which will allow spinouts, start-ups, and entrepreneurial minded academics to test their ideas and develop concepts with support from key stakeholders from the innovation ecosystem.

Read more
 Launch of Oncology Accelerator

05/05/2023

Launch of Oncology Accelerator

Innovate UK’s Cancer Therapeutics programme has launched an Oncology Accelerator to support the development of early-stage health and life science innovation in the UK.

Read more
More News

Sign up to our newsletter

Keep on top of all the latest funding opportunities and events within the Health & Life Sciences sector with our monthly newsletter.

Close

Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.